Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 6, 2011
Patent Application Number
12460991
Date Filed
July 28, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
Methods for treating renal cell carcinoma using low doses of IL-2 are disclosed. In particular, the invention relates to methods of treating metastatic renal cell carcinoma in patients who are renally impaired and/or intolerant of high dose IL-2 therapy. The therapeutic regimen described herein significantly inhibits tumor growth with reduced toxicity and adverse side effects compared to high dose IL-2 therapy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
